fusaric acid has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramautar, A | 1 |
| Mabandla, M | 1 |
| Blackburn, J | 1 |
| Daniels, WM | 1 |
1 other study available for fusaric acid and Acquired-Immune Deficiency Syndrome Dementia Complex
| Article | Year |
|---|---|
Inhibition of HIV-1 tat-induced transactivation and apoptosis by the divalent metal chelators, fusaric acid and picolinic acid-implications for HIV-1 dementia.
Topics: AIDS Dementia Complex; Apoptosis; Cells, Cultured; Chelating Agents; Flow Cytometry; Fusaric Acid; H | 2012 |